<DOC>
	<DOCNO>NCT02165293</DOCNO>
	<brief_summary>This single-center , open-label study investigate RO7033877 concentration plasma various lung compartment , include epithelial lining fluid ( ELF ) , alveolar macrophage ( AM ) healthy volunteer multiple intravenous ( IV ) administration . Bronchoscopy perform start last infusion Day 3 different timepoints . Blood , urine brochoalveolar lavage sample collect determine RO7033877 concentration . The anticipated time study treatment 3 day .</brief_summary>
	<brief_title>A Single Center Study Evaluate Penetration RO7033877 Into Lung Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Male female healthy volunteer , 18 55 year age , inclusive . A female participant eligible participate nonchildbearing potential define postmenopausal surgically sterile Healthy status define absence evidence active chronic disease follow detailed medical surgical history , complete physical examination include vital sign , 12lead electrocardiogram ( ECG ) , hematology , blood chemistry , serology urinalysis Body mass index ( BMI ) 18 30 kg/m2 inclusive Nonsmokers Healthy male volunteer female partner childbearing potential must use adequate contraception method Evidence active chronic disease Regular consumption drug abuse Infection human immunodeficiency virus ( HIV ) , hepatitis B ( HBV ) , hepatitis C ( HCV ) History clinically significant hypersensitivity allergic drug reaction Clinically significant abnormality ( e.g . cardiovascular , laboratory value ) Abnormal blood pressure vital sign Contraindications bronchoalveolar lavage ( BAL )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>